home / stock / nmtc / nmtc news

NMTC News and Press, NeuroOne Medical Technologies Corporation From 11/07/23

Stock Information
Company Name: NeuroOne Medical Technologies Corporation
Stock Symbol: NMTC
Market: NASDAQ
Website: n1mtc.com
Menu
NMTC NMTC Quote NMTC Short NMTC News NMTC Articles NMTC Message Board
Get NMTC Alerts

News, Short Squeeze, Breakout and More Instantly...
NMTC - NeuroOne® Provides Progress Update on FDA 510(k) Submission for OneRF(TM) Ablation System

Feedback from responses to FDA anticipated in 30 days Commercialization remains on track in first half of 2024 pending FDA clearance Product potential for transformative improvement in neurosurgery as first known sEEG-guided RF system that records and ablates nervous tis...
NMTC - NeuroOne® to Present at the ThinkEquity Conference on October 19, 2023

EDEN PRAIRIE, Minn., Oct. 13, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced t...

NMTC - NeuroOne® to Present at the H.C. Wainwright 25th Annual Global Investment Conference

EDEN PRAIRIE, Minn., Sept. 06, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced ...

NMTC - NeuroOne Medical Technologies Corporation (NMTC) Q3 2023 Earnings Call Transcript

2023-08-14 19:26:05 ET NeuroOne Medical Technologies Corporation (NMTC) Q3 2023 Results Conference Call August 14, 2023 04:30 PM ET Company Participants Dave Rosa - Chief Executive Officer Ron McClurg - Chief Financial Officer Presentation Operator ...
NMTC - NeuroOne Medical Technologies GAAP EPS of -$0.20

2023-08-14 16:59:50 ET NeuroOne Medical Technologies press release ( NASDAQ: NMTC ): Q3 GAAP EPS of -$0.20. Product revenue was $630,000 in the fiscal third quarter 2023, compared to product revenue of $32,000 in the fiscal third quarter 2022. For furt...

NMTC - NeuroOne® Reports Third Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update

EDEN PRAIRIE, Minn., Aug. 14, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announces i...

NMTC - NeuroOne® to Report Third Quarter Fiscal Year 2023 Financial Results and Provide a Corporate Update on August 14

EDEN PRAIRIE, Minn., Aug. 08, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will host a confe...
NMTC - YELL, RGTI and RMNI among mid-day movers

2023-07-25 12:09:08 ET Gainers: Electra Battery Materials ( ELBM ) +72% . Bullfrog AI Holdings ( BFRG ) +38% . Kiniksa Pharmaceuticals ( KNSA ) +30% . Steakholder Foods ( STKH ) +25% . Galecto ( GLTO ) +23% . Rigetti Computin...

NMTC - Bullfrog AI, Carmell, top healthcare gainers; NeuroOne, Stoke among losers

2023-07-25 10:18:59 ET Gainers: Bullfrog AI ( BFRG ) +35% . Carmell Therapeutics ( CTCX ) +32% . Kiniksa Pharmaceuticals ( KNSA ) +21% . Galecto ( GLTO ) +18% . Akebia Therapeutics ( AKBA ) +16% . Losers: NeuroOne Med...

NMTC - SOUN, VTNR and BBIG among pre-market losers

2023-07-25 08:22:48 ET NeuroOne Medical Technologies Corporation ( NMTC ) -35% . announces pricing of public offering of common stock . Stoke Therapeutics ( STOK ) -34% announces positive new safety & efficacy data from patients treated with STK-001 in the ...
Previous 10 Next 10